文献速递心脏核医学放射性药物与辐射防护

心内膜β发射放射性示踪剂检测与分子引导介入的原型装置

Prototype device for endoventricular beta-emitting radiotracer detection and molecularly-guided intervention.
PubMed 文献 · J Nucl Cardiol · 2020-08-20

本研究开发了一种导管式诊疗一体化系统,通过心内膜检测全身给药的β发射放射性示踪剂来识别病变和风险心肌,并利用分子信号引导心肌内注射治疗。原型装置在体外对22Na、18F和204Tl的β辐射敏感检测,对γ辐射敏感性低;在猪心肌梗死模型中心内膜18F活性测量与PET/CT和γ计数相关性良好。

要点

  • β检测导管可灵敏检测β+和β-发射体,对γ辐射敏感性低。
  • 18F接触灵敏度4067 counts/s/μCi,空间分辨率1.1 mm FWHM。
  • 猪心梗模型中心内膜18F测量与PET/CT及γ计数定性定量相关良好。

核心结论

  • 原型β检测导管能敏感且选择性地检测宽能量范围的β-和β+发射,并可在离体条件下高保真表征全身给药18F-FDG的心内膜活性。

研究设计与样本

  • 原型装置由柔性血管内导管尖端的微型β辐射探测器组成,可适配注射口和可伸缩针头用于治疗递送。
  • 体外用多种β发射放射性核素评估性能,离体在心肌梗死后1周的猪心脏中全身注射18F-FDG后评估。
  • 将导管基心内膜18F活性区域测量与PET/CT图像区域组织活性和γ计数进行比较。

主要发现

  • β检测导管在体外对22Na(β+)、18F(β+)和204Tl(β-)的β辐射显示敏感检测,对γ辐射敏感性低。
  • 对于18F,导管接触灵敏度为4067 counts/s/μCi,空间分辨率为1.1 mm FWHM。
  • 在慢性猪梗死模型中,心内膜18F活性的离体测量与PET/CT图像和γ计数的区域组织活性显示良好的定性和定量相关性。

临床怎么用

  • 该原型装置可能支持通过心内膜β检测识别病变和风险心肌,并利用分子信号引导心肌内治疗递送。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We have set out to develop a catheter-based theranostic system that: (a) identifies diseased and at-risk myocardium via endocardial detection of systemically delivered β-emitting radiotracers and (b) utilizes molecular signals to guide delivery of therapeutics to appropriate tissue via direct intramyocardial injection. METHODS: Our prototype device consists of a miniature β-radiation detector contained within the tip of a flexible intravascular catheter. The catheter can be adapted to incorporate an injection port and retractable needle for therapeutic delivery. The performance of the β-detection catheter was assessed in vitro with various β-emitting radionuclides and ex vivo in hearts of pigs following systemic injection of 18F-fluorodeoxyglucose (18F-FDG) at 1-week post-myocardial infarction. Regional catheter-based endocardial measurements of 18F activity were compared to regional tissue activity from PET/CT images and gamma counting. RESULTS: The β-detection catheter demonstrated sensitive in vitro detection of β-radiation from 22Na (β+), 18F (β+), and 204Tl (β-), with minimal sensitivity to γ-radiation. For 18F, the catheter demonstrated a sensitivity of 4067 counts/s/μCi in contact and a spatial resolution of 1.1 mm FWHM. Ex vivo measurements of endocardial 18F activity with the β-detection catheter in the chronic pig infarct model demonstrated good qualitative and quantitative correlation with regional tissue activity from PET/CT images and gamma counting. CONCLUSION: The prototype β-detection catheter demonstrates sensitive and selective detection of β- and β+ emissions over a wide range of energies and enables high-fidelity ex vivo characterization of endocardial activity from systemically delivered 18F-FDG.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Stendahl JC, Liu Z, Boutagy NE, et al. Prototype device for endoventricular beta-emitting radiotracer detection and molecularly-guided intervention. J Nucl Cardiol. 2020. PMID: 32820423. doi:10.1007/s12350-020-02317-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。